| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6241046 | Respiratory Medicine | 2016 | 9 Pages |
Abstract
Omalizumab improves all asthma outcomes independently of age, although the magnitude of the effects observed in the elderly seems to be lower than in the other age groups.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
B. Sposato, M. Scalese, M. Latorre, N. Scichilone, A. Matucci, M. Milanese, S. Masieri, G. Rolla, G. Steinhilber, Y. Rosati, A. Vultaggio, I. Folletti, S. Baglioni, E. Bargagli, M. Di Tomassi, R. Pio, A. Pio, U. Maccari, P.L. Paggiaro,